Tibet Duo Rui Pharmaceutical Co., Ltd. (SHE:301075)
China · Delayed Price · Currency is CNY 48.53
+0.25 (0.52%)
Jul 29, 2026, 4:00 PM EDT
SHE:301075 Revenue
Tibet Duo Rui Pharmaceutical had revenue of 32.43M CNY in the quarter ending March 31, 2026, a decrease of -34.41%. This brings the company's revenue in the last twelve months to 137.16M, down -43.00% year-over-year. In the year 2025, Tibet Duo Rui Pharmaceutical had annual revenue of 154.18M, down -35.93%.
Revenue (ttm)
137.16M
Revenue Growth
-43.00%
P/S Ratio
27.94
Revenue / Employee
297.54K
Employees
461
Market Cap
3.83B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 154.18M | -86.45M | -35.93% |
| Dec 31, 2024 | 240.63M | -93.67M | -28.02% |
| Dec 31, 2023 | 334.30M | -66.75M | -16.64% |
| Jan 1, 2023 | 401.05M | -128.57M | -24.28% |
| Jan 1, 2022 | 529.62M | 39.45M | 8.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Bioengineering | 25.24B |
| Hunan Fangsheng Pharmaceutical | 1.79B |
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 1.78B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 1.68B |
| Bide Pharmatech | 1.35B |
| LanZhou Foci Pharmaceutical | 910.98M |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 843.87M |
| Harbin Medisan Pharmaceutical | 813.23M |